Daniel Rochefort

Title: The Innovations of Daniel Rochefort

Introduction

Daniel Rochefort is a notable inventor based in Laval, Canada. He has made significant contributions to the field of epilepsy research, particularly in understanding idiopathic generalized epilepsy (IGE). His work focuses on identifying genetic factors that contribute to this neurological disorder.

Latest Patents

Rochefort holds a patent titled "SCN3A locus for idiopathic generalized epilepsy, mutations thereof and method using same." This invention relates to the identification of three genes mapping to chromosome 2, which show mutations in patients with epilepsy. The patent encompasses nucleic acid sequences and protein sequences of these loci (SCNA) and their applications in assessing, diagnosing, prognosing, or treating epilepsy. It also aims to predict an epileptic individual's response to medication and identify agents that modulate the function of the SCNA. Furthermore, the invention provides screening assays using SCN1A, SCN2A, and/or SCN3A to identify compounds with therapeutic benefits for epilepsy and related neurological disorders.

Career Highlights

Throughout his career, Rochefort has focused on advancing the understanding of epilepsy through innovative research. His work has implications for both diagnosis and treatment, potentially improving the lives of many individuals affected by this condition.

Collaborations

Rochefort has collaborated with esteemed colleagues such as Guy A Rouleau and Ronald G Lafreniere. These partnerships have enhanced the depth and impact of his research in the field of epilepsy.

Conclusion

Daniel Rochefort's contributions to epilepsy research through his innovative patent highlight the importance of genetic understanding in treating neurological disorders. His work continues to pave the way for advancements in the field.